Youyi Fong Selected Research

Complement System Proteins (Complement)

2/2024

Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Youyi Fong Research Topics

Disease

15	COVID-19 02/2024 - 12/2020
14	Infections 01/2023 - 04/2012
6	Dengue (Dengue Fever) 10/2023 - 01/2018
5	Communicable Diseases (Infectious Diseases) 03/2024 - 07/2015
5	HIV Infections (HIV Infection) 01/2022 - 12/2014
2	Disease Progression 01/2019 - 08/2014
1	Hypoxia (Hypoxemia) 01/2023
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2023
1	Human Influenza (Influenza) 05/2019
1	Cholera 01/2018
1	Bites and Stings (Sting) 01/2018
1	Virus Diseases (Viral Diseases) 05/2015
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2014
1	Inflammation (Inflammations) 01/2014
1	Parakeratosis 01/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2013

Drug/Important Bio-Agent (IBA)

35	VaccinesIBA 03/2024 - 04/2012
13	Immunoglobulin G (IgG)IBA 03/2023 - 04/2012
12	Neutralizing AntibodiesIBA 10/2023 - 01/2018
6	Biomarkers (Surrogate Marker)IBA 03/2024 - 05/2015
6	AntibodiesIBA 01/2023 - 04/2012
4	Proteins (Proteins, Gene)FDA Link 02/2024 - 04/2012
4	Dengue VaccinesIBA 10/2023 - 01/2018
4	2019-nCoV Vaccine mRNA-1273IBA 01/2023 - 08/2021
4	Immunoglobulin A (IgA)IBA 11/2019 - 04/2012
3	Fc Receptors (Fc Receptor)IBA 01/2019 - 09/2014
3	AIDS VaccinesIBA 01/2018 - 04/2013
2	NVX-CoV2373 adjuvated lipid nanoparticleIBA 02/2024 - 01/2023
2	Ad26COVS1IBA 12/2022 - 04/2022
2	CYD-TDV vaccineIBA 01/2019 - 01/2018
2	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2014
1	mRNA VaccinesIBA 02/2024
1	Complement System Proteins (Complement)IBA 02/2024
1	ChAdOx1 nCoV-19IBA 03/2023
1	casirivimab and imdevimab drug combinationIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2023
1	COVID-19 VaccinesIBA 04/2022
1	Broadly Neutralizing AntibodiesIBA 01/2022
1	IgG Receptors (Fc gamma RI)IBA 11/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2019
1	Neuraminidase (Sialidase)IBA 05/2019
1	Influenza Vaccines (Influenza Vaccine)FDA Link 05/2019
1	Polysaccharides (Glycans)IBA 01/2019
1	Antimalarials (Antimalarial Agents)IBA 01/2018
1	DSM265IBA 01/2018
1	Dihydroorotate DehydrogenaseIBA 01/2018
1	Vaccine AdjuvantsIBA 01/2018
1	Cholera Vaccines FDA Link 01/2018
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2018
1	Fibronectins (Fibronectin)IBA 01/2014
1	Glycoproteins (Glycoprotein)IBA 01/2014
1	AntigensIBA 01/2014
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2014
1	Chemokine CCL5IBA 01/2014

Therapy/Procedure

1	Male Circumcision 01/2014